Figure 2From: Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept Event-free Survival: EFS was 90.0% at 12 months, 85.0% at 24 months, 68.3% at 60 months and 54.9% at 120 months (Kaplan-Meier, n = 20).Back to article page